Elsemieke I. Plasmeijer

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

Irene L. M. Reijers, Disha Rao, Judith M. Versluis et al. · The Journal of Experimental Medicine · 2023 · 74 citations · Full text

Medicine, Immunology, Oncology +17

Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation

Martin Vos, Elsemieke I. Plasmeijer, Barbara C. van Bemmel et al. · The Journal of Heart and Lung Transplantation · 2018 · 68 citations

Medicine, Oncology, Pharmacotherapy +11

Metastasis Risk of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients and Immunocompetent Patients

Roel E. Genders, J. Osinga, E Tromp et al. · Acta Dermato Venereologica · 2018 · 61 citations · Full text

Medicine, Dermatology, Oncology +17

A Lack of Birbeck Granules in Langerhans Cells Is Associated with a Naturally Occurring Point Mutation in the Human Langerin Gene

Pauline Verdijk, Remco Dijkman, Elsemieke I. Plasmeijer et al. · Journal of Investigative Dermatology · 2005 · 51 citations · Full text

Life Sciences, Genetics, Molecular Genetics +7

The Presence of Betapapillomavirus Antibodies around Transplantation Predicts the Development of Keratinocyte Carcinoma in Organ Transplant Recipients: A Cohort Study

Roel E. Genders, Hadi Mazlom, Angelika Michel et al. · Journal of Investigative Dermatology · 2014 · 41 citations

Medicine, Dermatology, Oncology +15